Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

Switzerland: CordenPharma expands global peptides platform in US and China

Buy Out Nick Herbert -
Switzerland-based global CDMO, CordenPharma, has agreed to acquire AmbioPharm, a US-headquartered peptide API CDMO, from Carlyle. The acquisition builds on CordenPharma’s global facility network of 11 sites in Europe and North America. AmbioPharm employs approximately 400 people across its two sites in South Carolina and Shanghai, which add differentiated peptide manufacturing...

Sweden: HealthCap invests in Neobiomics to support continued growth in neonatal care

Life Sciences Nick Herbert -
Neobiomics, a Swedish life science company focused on improving outcomes for preterm infants through evidence-based nutritional products, has received an investment led by HealthCap, a specialist provider of life sciences venture capital in Europe.  “HealthCap brings deep life science expertise, a strong international network, and extensive experience in building global life science companies,” said Emma Höglund, CEO of Neobiomics. “This investment is an important milestone for Neobiomics and supports our ambition to bring evidence-based neonatal solutions to more infants worldwide.” HealthCap’s investment will support Neobiomics’ commercial expansion, international growth, and further...